Cann Group (ASX:CAN) has unveiled a major financial reset, announcing an 81 per cent reduction in debt and a $9 million capital raising, providing what CEO Jenni Pilcher describes as “a clean foundation” for the company’s next phase of growth. …
Cann Group announces major debt restructure and capital raise to strengthen balance sheet
October 27, 2025 Australian Biotech
Latest Video
New Stories
-
The 'Dispatched' Podcast - Series 5, Ep .24
July 17, 2026 - - Podcast -
Ex-Novartis leader joins the board of emerging nuclear medicine company
July 17, 2026 - - Latest News -
It doesn't always feel like it, but make no mistake, this is what winning looks like
July 17, 2026 - - Latest News -
Telix opens Australia's first integrated radiopharmaceutical facility in Melbourne
July 16, 2026 - - Latest News -
A single payer system in which the worst kind of inequity is the only one permitted
July 16, 2026 - - Latest News -
Organon and Samsung Bioepis expand partnership to broaden biosimilar access in Australia
July 16, 2026 - - Latest News -
Arthritis Australia unveils new grants and identity as research breakthroughs loom
July 16, 2026 - - Latest News